Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1

Conditions

Pancreatic Neoplasms 2Prostatic Hyperplasia 1Pancreatic Diseases 1Lymphoma, Follicular 1Lung Cancer Metastatic 1

Interventions

Dutasteride 4Prostatectomy 2proxalutamide 1polyphenon E 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Therapeutics 1Tamsulosin 1Standard of Care 1Risedronic Acid 1Psychiatric Rehabilitation 1Prostate-Specific Antigen 1Oxygen 1Nitrous Oxide 1Needles 1Microspheres 1Lycopene 1Levofloxacin 1Electroacupuncture 1Doxazosin 1Dexmedetomidine 1Celecoxib 1Biopsy 1Biofeedback, Psychology 1Amyloid 1Adrenergic alpha-Antagonists 1Acupuncture Therapy 15-alpha Reductase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Prostatic Hyperplasia × Needles × Clear all
NCT01218243 2013-05-27

An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Phase 2 Completed
100 enrolled 14 charts
GenitourinaryLymphoid

Lymphoma, Follicular, Prostatic Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡